FULLY FUNDED TERTIARY QUALIFICATION LAUNCHES TO ADDRESS PERINATAL MENTAL HEALTH CLINICIAN SHORTAGE IN AUSTRALIAN-FIRST Tertiary qualification launched by Gidget Foundation and Federation University.
With Arabella Gibson, CEO
Gidget Foundation Australia
SEGMENT
Filmed in North Sydney | January 2025
Demand for perinatal mental health services is continuing to surge year-on-year. In fact, perinatal mental health organisation, Gidget Foundation Australia (GFA), has supported 30% more clients in FY2024 than in FY2023, up by 214% since FY2021.
Perinatal depression and anxiety (PNDA) impacts 100,000 Australians each year, equating to one in five mums and one in ten dads, with PNDA costing Australia $877 million annually. To address the nationwide shortage of specialist perinatal mental health clinicians, Gidget Foundation Australia has partnered with Federation University to launch the Graduate Diploma in Perinatal Mental Health.
Australian Health Journal met with Arabella Gibson, CEO Gidget Foundation Australia following the announcement to hear about the Gidget mission and the new initiative to address the perinatal mental health clinician shortage.
The new Graduate Diploma in Perinatal Mental Health creates a unique offering in the industry, providing comprehensive ‘on the job’ training, weekly supervision for clinicians, academic modules and a paid placement opportunity as well as ongoing employment through Gidget Foundation Australia’s face-to-face or telehealth services.
The new partnership, create an Australian-first offering of a fully supported tertiary qualification. Gidget Foundation Australia and Federation University have engaged in the unique co-design and co-delivery of the qualification, with both organisations developing and delivering practical and theoretical course content.
Ms Gibson says the Gidget Foundation, with Federation University, is committed to ensuring robust clinical standards are achieved through providing exceptional education for clinicians working in the perinatal space.
“We’ve seen demand for perinatal depression and anxiety support continue to rise, our clinicians supported 30% more clients in FY2024 than in FY2023. It’s essential we have enough qualified clinicians to meet this growing demand to address the critical needs of the individuals impacted.
“Equity, access, and affordability can be a barrier for allied health professionals to further extend their professional knowledge and skills. The Graduate Diploma in Perinatal Mental Health enables health professionals to upskill in perinatal and infant mental health and creates an accessible pathway to enhance knowledge and experience across the sector; whilst benefitting the health professional, clients, and the wider community.”, says Ms Gibson.
The first cohort of the new Graduate Diploma in Perinatal Mental Health will graduate in July 2025 and applications opened in November 2024 for the February 2025 intake.
-
HEALTH CARE BRIEF: Anaphylaxis
Anaphylaxis – Incidence rates, risks, causes, management, population trends & research
-
Still seeking outcomes after 6th Stoma Appliance Scheme Schedule Review
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
-
Improved treatment in advanced-stage Hodgkin lymphoma
A global clinical trial successfully reduced toxicity and side effects in advanced stage Hodgkin lymphoma patients by using a modified treatment regimen.
Australian Health Journal spoke with Professor Mark Hertzberg in his role in the ALLG HD10 Clinical Trial and as a former Chair of the Scientific Advisory Committee of the Australasian Leukaemia & Lymphoma Group (ALLG), an organisation involved in improving the treatments and lives of blood cancer patients.
